For 18 years, Truffle Capital has been creating and financing to success radical and disruptive innovations in two fields of expertise, Life Sciences and Information Technologies. These creations revolutionize their sectors and will become the tomorrow’s leaders.
Truffle Capital is the only European Fund to support its innovations from creation to commercial success.
Truffle Capital works closely with the world's best 50 universities to select and transform their most significant inventions into major technological innovations, novel medical devices and effective drug treatments.
In terms of Information technologies, Truffle Capital has focused in FinTechs since 2014. Thanks to its team of dedicated experts, Truffle is able to select products & services with underlying complex technologies (deep tech).
Truffle capital announces the results of fintech100 ranking !
Truffle Capital announces the results of the 1st Fintech100 ranking, in partnership with Finance Innovation, Groupe BPCE and Sopra Steria
Interview of Philippe Pouletty by Hedwige Chevrillon in "Le Grand Journal de l'Éco" on BFM Business TV
"Radically innovative science solves environment and health issues"
Carbios to build in france its first-of-a-kind manufacturing plant for fully bio-recycled PET
The plant will have a capacity to process 50,000 metric tons of plastic waste per year
RollingFunds raises over 5 million euros
Rollingfunds raises €5m to accelerate the deployment of its credit automation technology.
Truffle launchs the Fintech 100, a ranking of French fintechs and insurtechs
Creation of the Fintech 100 ranking, in partnership with Finance Innovation, Groupe BPCE, Sopra Steria Group and Sopra Banking Software
OBAT, a new investment
Digitizing invoicing and payment for SMEs in the construction sector